Post-Implant Phosphodiesterase-5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-Analysis.
Αndrew XanthopoulosDimitrios E MagouliotisKonstantinos TryposkiadisProkopis-Andreas ZotosKyriakos SpiliopoulosThanos AthanasiouGrigorios GiamouzisIoannis SkoularigisRandall C StarlingFilippos TriposkiadisPublished in: Journal of clinical medicine (2022)
The use of PDE-5i post-implant was associated with lower mortality and thrombotic events but with a higher risk of gastrointestinal bleeding.